Flurbiprofen axetil or dezocine monotherapy has been applied for analgesia of postoperative non-small cell lung cancer (NSCLC); however, their combination is rarely investigated. Consequently, the present study aimed to explore the effect of flurbiprofen axetil plus dezocine on postoperative pain, surgical outcomes and its safety profile in patients with NSCLC. A total of 150 patients with resectable NSCLC were enrolled and randomized into three groups: i) The flurbiprofen axetil plus dezocine group (n=50), ii) the flurbiprofen axetil group (n=51) and iii) the dezocine group (n=49). A total of 50 mg flurbiprofen axetil, 5 mg of dezocine or their combination were administered intravenously 3 h prior to surgery and subsequently every 12 h until day 3 (D3) following surgery. The postoperative pain was lower in the flurbiprofen axetil plus dezocine group compared with that of the flurbiprofen axetil group at 6 h (P=0.008), 12 h (P=0.003), day 1 (D1) (P=0.013), day 2 (D2) (P=0.036) and D3 (P=0.010); in addition, it was lower in the flurbiprofen axetil plus dezocine group compared with that of the dezocine group at 6 h (P=0.010), 12 h (P=0.012) and D1 (P=0.020). Patient-controlled analgesia consumption was also lower in the flurbiprofen axetil plus dezocine group compared with that of the flurbiprofen axetil (P=0.010) and dezocine (P=0.002) groups. Furthermore, the length of hospital stay was lower in the flurbiprofen axetil plus dezocine group compared with that of the flurbiprofen axetil (P=0.008) and dezocine (P=0.048) groups, while other surgical outcomes and adverse events were similar among these three groups. Moreover, the expression of tumor necrosis factor-α was lower in the flurbiprofen axetil plus dezocine group compared with that of the dezocine group at 12 h (P<0.001), D1 (P<0.001) and D3 (P=0.033). The data indicated that flurbiprofen axetil and dezocine combination was superior to monotherapy for postoperative analgesia in patients with resectable NSCLC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082835PMC
http://dx.doi.org/10.3892/ol.2024.14426DOI Listing

Publication Analysis

Top Keywords

flurbiprofen axetil
56
axetil dezocine
40
dezocine group
36
lower flurbiprofen
20
group compared
20
dezocine
15
axetil
14
flurbiprofen
13
compared flurbiprofen
12
group
11

Similar Publications

Efficacy of thumbtack needle acupuncture combined with PCIA on patients after laparoscopic myomectomy: a randomized controlled trial.

Front Med (Lausanne)

November 2024

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China.

Article Synopsis
  • - The study investigates the effectiveness of thumbtack needle acupuncture (TNA) combined with patient-controlled intravenous analgesia (PCIA) to improve recovery after laparoscopic myomectomy (LM), addressing pain and gastrointestinal issues that hinder same-day discharge.
  • - 52 patients were randomly assigned to receive either TNA or standard care, and various pain and recovery metrics were measured, including Visual Analog Scale (VAS) scores and gastrointestinal function.
  • - Results showed that the TNA group had significantly lower pain scores, reduced need for additional pain medications, quicker gastrointestinal recovery, and shorter hospital stays compared to the control group, indicating TNA may enhance post-surgery outcomes.
View Article and Find Full Text PDF

Background: With an aging population, knee arthroplasty is increasingly common; however, chronic postsurgical pain (CPSP) affects up to 30% of patients. This study aims to evaluate the efficacy of 5% lidocaine-medicated plaster (LP5) in preventing CPSP among patients undergoing knee arthroplasty.

Methods: This is a dual-center, randomized, double-blind, placebo-controlled trial involving 128 adult patients scheduled for knee arthroplasty.

View Article and Find Full Text PDF

Flurbiprofen axetil is commonly utilized in clinical practice as one of the nonsteroidal anti-inflammatory drugs (NSAIDs) and is included in multimodal analgesia regimens postbreast cancer surgery. Numerous NSAIDs have been studied for their potential to both promote and inhibit cancer. Given the variability in their effects on tumors, further investigation into the specific role of flurbiprofen axetil is warranted.

View Article and Find Full Text PDF

Background: Multimodal analgesic strategy is pivotal for enhanced recovery after surgery. The objective of this trial was to assess the effect of subanesthetic esketamine vs. placebo combined with erector spinae plane block (ESPB) vs.

View Article and Find Full Text PDF
Article Synopsis
  • Postoperative nausea and vomiting (PONV) are common and negatively impact patients after thyroid and parathyroid surgeries; the study aimed to see if opioid-free propofol anesthesia could lower these occurrences.
  • A randomized trial involving 394 patients showed that those receiving opioid-free anesthesia had a significantly lower rate of PONV (5%) compared to those with opioid-inclusive anesthesia (24%).
  • Other benefits of opioid-free anesthesia included fewer rescue anti-emetic needs, reduced hypotension and desaturation post-surgery, and higher patient satisfaction, while slightly delaying tracheal extubation time.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!